Butterfly Network, Inc.

Butterfly Network manufactures and distributes the iQ3, a handheld, whole-body portable ultrasound probe for point-of-care ultrasound (POCUS) applications. The iQ3 integrates advanced AI-powered diagnostic capabilities, workflow management software, and a comprehensive education suite to enable clinicians across emergency medicine, primary care, obstetrics, and specialty practices to perform real-time ultrasound assessments at the bedside or point of care. The company serves individual practitioners, health systems, hospitals, and medical education institutions. Products include the iQ3 probe (FDA-cleared), with an established installed base of 145,000+ customers globally. The iQ3 represents an upgrade path from earlier Butterfly models (iQ, iQ+); trade-in programs are offered. Key software platform: Compass AI, a POCUS management module designed to centralize ultrasound workflows across health systems. Clinical applications include obstetric gestational age assessment, lung ultrasound (B-line detection), cardiac evaluation, and emergency diagnostic imaging. The company publishes clinical evidence demonstrating impact on patient outcomes, including reduced length of stay and improved charge capture in hospital deployments. Regulatory credentials include FDA 510(k) clearance. The platform emphasizes ease of use, portability, and seamless integration into clinical workflows for both resource-constrained and academic medical environments.